Advertisement

Catheter Ablation of Ventricular Tachycardia

  • Guy Fontaine
  • Jérôme Lacotte
  • Françoise Hidden-Lucet
  • Robert Frank

Abstract

Antiarrhythmic surgery (ventriculotomy) was used in our institution between 1973 and 1980 to treat 15 patients with Arrhythmogenic Right Ventricular Dysplasia (ARVC/D) who had ventricular tachycardia (VT) resistant to antiarrhythmic drug therapy. When catheter ablative procedures became available, we used fulguration (F) with DC energy shock alone in 27 patients between August 1983 and February 1992. However, this technique was associated with serious complications. The causes of these complications are now understood and the problems associated with F have been corrected. We now use radiofrequency (RF) energy followed by F if RF ablation is not successful. This protocol has been used in 23 patients from 1992 until October, 1999. The results of ablation using these two approaches over 16 years has been reported [1]. We wish to report our most recent experience with 22 additional patients over 6 years using the combined treatment with RF ablation immediately followed by the use of F if necessary.

Keywords

Ventricular Tachycardia Catheter Ablation Arrhythmogenic Right Ventricular Dysplasia Catheter Ablative Procedure Epicardial Ablation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fontaine G, Tonet J, Gallais Y et al (2000) Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: A 16-year experience. Curr Cardiol Rep 2:498–506PubMedCrossRefGoogle Scholar
  2. 2.
    McKenna WJ, Thiene G, Nava A et al (1994) Diagnosis of arrhythmogenic right ventricula dysplasia/cardiomyopathy. Br Heart J 71:215–218PubMedCrossRefGoogle Scholar
  3. 3.
    Tonet J, Himbert C, Johnson N et al (2000) Prolongation of ventricular refractoriness and ventricular tachycardia cycle length by the combination of oral beta-blocker — Amiodarone in patients with ventricular tachycardia. PACE 23:565Google Scholar
  4. 4.
    Langberg J, Lee MA, Chin M, Rosenqvist M (1990) Radiofrequency catheter ablation: The effect of electrode size on lesion volume in vivo. PACE 13:1242–1248PubMedGoogle Scholar
  5. 5.
    Fontaine G, Cansell A, Lampe L et al (1987) Endocavitary fulguration (electrode catheter ablation): Equipment-related problems. In: Fontaine G, Scheiman MM (eds) Ablation in cardiac arrhythmias. Futura, Kisko, NY pp 85–100Google Scholar
  6. 6.
    Gallais Y, Lascault G, Tonet J et al (1993) Continuous measurement of coronary sinus oxygen saturation during ventricular tachycardia (abstract). Eur Heart J 14:368Google Scholar
  7. 7.
    Morady F, Frank R, Kou WH et al (1988) Identification and catheter ablation of a zone of slow conduction in the reentry. Circuit of ventricular tachycardias in humans. J Am Coll Cardiol 11:775–782PubMedCrossRefGoogle Scholar
  8. 8.
    Fontaine G, Frank R, Tonet J, Grosgogeat Y (1989) Identification of a zone of slow conduction appropriate for VT ablation. Theoretical and practical considerations. PACE 12:262–267PubMedGoogle Scholar
  9. 9.
    Stevenson WG, Khan H, Sager P et al (1993) Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 88:1647–1670PubMedGoogle Scholar
  10. 10.
    Man KC, Daoud E, Knight BP et al (1997) Accuracy of the unipolar electrogram for identification of the site of origin of ventricular activation. J Cardiovasc Electrophysiol 8:974–979PubMedCrossRefGoogle Scholar
  11. 11.
    Harada T, Aonuma K, Yamauchi S et al (1998) Catheter ablation of ventricular tachycardia in patients with right ventricular dysplasia: Identification of target sites by entrainment mapping techniques. PACE 21:2547–2550PubMedGoogle Scholar
  12. 12.
    Fontaliran F, Arkwright S, Vilde F, Fontaine G (1998) Arrhythmogenic right ventricular dysplasia and cardiomyopathy. Clinical and anatomic-pathologic aspects, nosologic approach. Arch Anat Cytol Pathol 46:171–177PubMedGoogle Scholar
  13. 13.
    Fontaine G, Fontaliran F, Rosas Andrade F et al (1995) Arrhythmogenic right ventricle: Dysplasia or cardiomyopathy? Value of left ventricle ejection fraction. Ann Cardiol Angeiol 44:321–331Google Scholar
  14. 14.
    Hulot JS, Jouven X, Empana JP et al (2004) Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110:1879–1884PubMedCrossRefGoogle Scholar
  15. 15.
    Feld GK (1998) Expanding indications for radiofrequency catheter ablation: Ventricular tachycardia in association with right ventricular dysplasia. J Am Coll Cardiol 32:729–731PubMedCrossRefGoogle Scholar
  16. 16.
    Wichter T, Hindricks G, Kottkamp H et al (1997) Catheter ablation of ventricular tachycardia. In: Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Nava A, Rossi L, Thiene G (eds) Elsevier Science BV, Amsterdam, pp 376–391Google Scholar
  17. 17.
    Marchlinski FE, Zado E, Dixit S et al (2004) Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110:2293–2298PubMedCrossRefGoogle Scholar
  18. 18.
    Fontaine G, Fontaliran F, Lascault G et al (1994) Arrhythmogenic right ventricular dysplasia. In: Cardiac electrophysiology. From cell to bedside. Zipes DP, Jalife J (eds) WB Saunders, Philadelphia, pp 754–768Google Scholar
  19. 19.
    Verma A, Kiliscaslan F, Schweikert RA et al (2005) Short-and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation 111:3209–3216PubMedCrossRefGoogle Scholar
  20. 20.
    Marchlinski FE, Zado E, Dixit S et al (2004) Electroanatomic substrate of catheter ablation therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110:2293–2298PubMedCrossRefGoogle Scholar
  21. 21.
    Manaka T, Shoda M, Tanisaki K et al (2005) Electrophysiological properties and long term outcome of catheter ablation for ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy — A single center experience. Circulation 112:624CrossRefGoogle Scholar
  22. 22.
    Soejima K, Stevenson WG, Sapp JL et al (2004) Endocardial and epicardial Radiofrequency ablation of ventricular tachycardia with dilated cardiomyopathy: The importance of low voltage scars. J Am Coll Cardiol 43:1834–1842PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Guy Fontaine
    • 1
  • Jérôme Lacotte
    • 1
  • Françoise Hidden-Lucet
    • 1
  • Robert Frank
    • 1
  1. 1.Department of Cardiac Arrhythmias, Institute of CardiologyUniversity Hospital and School of Medicine Pitié-SalpêtrièreParisFrance

Personalised recommendations